J&J's $21B Synthes Buy Gets EU Nod After Divestiture

Law360, New York (April 19, 2012, 1:04 PM EDT) -- Johnson & Johnson won approval Thursday in the European Union for the company's $21.3 billion purchase of Swiss orthopedic device maker Synthes Inc., after J&J offered to sell off its worldwide trauma business to ease regulatory concerns.

The European Commission signed off on the deal after J&J said it would divest its entire trauma business, currently operated by the company's DePuy Orthopaedics Inc. unit, in an effort to allay the watchdog's antitrust worries. The proposed sale of the DePuy trauma unit “removes the overlap in the...
To view the full article, register now.